Several reports describe controversial data about plasma levels of IL-4 and IL-13 in individuals with PCC (77, 83, 84), but this is the first report about the higher capacity of Th2 cells from people with PCC to express these anti-inflammatory cytokines. This evidence concerns the gene IL4 and adrenal gland pheochromocytoma.